Sharma East India Hospitals & Medical Research Ltd (BOM:524548)
India · Delayed Price · Currency is INR 100.45
-2.55 (-2.48%)
At close: Jun 17, 2026
BOM:524548 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 359.33 | 298.72 | 185.23 | 207.26 | 170.38 |
Other Revenue | 1.56 | - | - | - | - |
| 360.89 | 298.72 | 185.23 | 207.26 | 170.38 | |
Revenue Growth (YoY) | 20.81% | 61.27% | -10.63% | 21.64% | 109.56% |
Cost of Revenue | 143.55 | 107.19 | 58.13 | 67.01 | 53.46 |
Gross Profit | 217.35 | 191.54 | 127.1 | 140.24 | 116.92 |
Selling, General & Admin | 141.21 | 122.6 | 123.37 | 84.38 | 67.76 |
Other Operating Expenses | 38.19 | 32.42 | 22.5 | 22.86 | 26.6 |
Operating Expenses | 196.6 | 173.39 | 160.66 | 121.14 | 102.16 |
Operating Income | 20.75 | 18.15 | -33.56 | 19.1 | 14.75 |
Interest Expense | -5.11 | -6.33 | -8.36 | -11.81 | -7.02 |
Interest & Investment Income | - | 1.58 | 0.84 | - | - |
Other Non Operating Income (Expenses) | - | -0.81 | -1.11 | 0.64 | 0.59 |
EBT Excluding Unusual Items | 15.64 | 12.59 | -42.19 | 7.93 | 8.32 |
Gain (Loss) on Sale of Assets | - | 1.54 | 52.23 | - | - |
Pretax Income | 15.64 | 14.13 | 10.04 | 7.93 | 8.32 |
Income Tax Expense | 3.22 | 1.69 | 3.41 | -0.41 | 1.52 |
Net Income | 12.43 | 12.44 | 6.63 | 8.34 | 6.8 |
Net Income to Common | 12.43 | 12.44 | 6.63 | 8.34 | 6.8 |
Net Income Growth | -0.13% | 87.68% | -20.50% | 22.63% | 6.73% |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 |
Shares Change (YoY) | 0.11% | - | 16.55% | -14.24% | 0.03% |
EPS (Basic) | 3.78 | 3.79 | 2.02 | 2.96 | 2.07 |
EPS (Diluted) | 3.78 | 3.79 | 2.02 | 2.96 | 2.07 |
EPS Growth | -0.24% | 87.68% | -31.79% | 42.99% | 6.70% |
Free Cash Flow | -46.69 | 29.28 | -26.81 | -23.63 | -0.87 |
Free Cash Flow Per Share | -14.20 | 8.92 | -8.16 | -8.38 | -0.27 |
Gross Margin | 60.22% | 64.12% | 68.62% | 67.67% | 68.62% |
Operating Margin | 5.75% | 6.08% | -18.12% | 9.22% | 8.66% |
Profit Margin | 3.44% | 4.17% | 3.58% | 4.02% | 3.99% |
Free Cash Flow Margin | -12.94% | 9.80% | -14.47% | -11.40% | -0.51% |
EBITDA | 37.95 | 36.51 | -18.76 | 33 | 22.56 |
EBITDA Margin | 10.51% | 12.22% | -10.13% | 15.92% | 13.24% |
D&A For EBITDA | 17.2 | 18.37 | 14.8 | 13.9 | 7.8 |
EBIT | 20.75 | 18.15 | -33.56 | 19.1 | 14.75 |
EBIT Margin | 5.75% | 6.08% | -18.12% | 9.22% | 8.66% |
Effective Tax Rate | 20.55% | 11.93% | 33.94% | - | 18.28% |
Revenue as Reported | 340.89 | 301.86 | 238.3 | 207.9 | 170.97 |
Advertising Expenses | - | 0.17 | 0.42 | - | - |